Main Session
Sep
29
PQA 03 - Central Nervous System, Professional Development/Medical Education
2616 - Cost-Effectiveness of Vorasidenib for Patients with Isocitrate Dehydrogenase (IDH) Mutated Low-Grade Glioma (LGG)
Presenter(s)
Adam Kessel, MD - Mayo Clinic Rochester, Rochester, MN